Halim Alia, Shirazi Haider, Riaz Sadia, Gul Syeda Shireen, Ali Wahid
Department of Neonatology, Children Hospital PIMS, Islamabad, Pakistan.
J Coll Physicians Surg Pak. 2019 Mar;29(3):226-330. doi: 10.29271/jcpsp.2019.03.226.
To compare the need of mechanical ventilation between LISA (less invasive surfactant administration) method and conventional INSURE method (INtubation SURfactant administration and Extubation) in spontaneously breathing preterm infants with respiratory distress syndrome (RDS).
An experimental study.
Department of Neonatology, PIMS, Islamabad, from April to December 2017.
A total of 100 preterm infants <34 weeks gestation, on nasal CPAP requiring fraction of inspire oxygen (FiO2) >0.4, with respiratory distress syndrome (RDS) were included in the study and divided randomly into two groups, 50 each.
There were 28 (56%) males in LISA and 31 (62%) in the INSURE group. Median birth weight was 1300 grams (IQR 600) in LISA, while 1400 grams (IQR 400) in INSURE infants. C-section rate was 52% (n=26) and 48% (n=24) in LISA and INSURE, respectively. Pre-natal steroids were given to 38 patients (76%) in LISA and 30 patients (60%) in INSURE group. LISA patients had significantly less need of mechanical ventilation with p-value <0.05 {30% (n=15) vs. 60% (n=30)}. The median duration of mechanical ventilation was 40 hours (IQR 75) and 71 hours (IQR 62) in LISA and INSURE, respectively. Similarly, median FiO2 reduction was 30 (IQR 30) in LISA group and it was 25 (IQR 10) in INSURE group, with p-value <0.05. There was no significant difference in mortality, hospital stay and complications.
LISA technique was safe, non-invasive approach of surfactant administration, with reduced need of mechanical ventilation rate and duration.
比较在患有呼吸窘迫综合征(RDS)的自主呼吸早产儿中,肺表面活性物质微创给药(LISA)法与传统INSURE法(气管插管-肺表面活性物质给药-拔管)对机械通气的需求。
一项实验研究。
2017年4月至12月,伊斯兰堡巴基斯坦医学科学研究所新生儿科。
本研究共纳入100例孕周<34周、因呼吸窘迫综合征(RDS)在鼻持续气道正压通气(CPAP)下吸入氧分数(FiO2)>0.4的早产儿,并随机分为两组,每组50例。
LISA组有28例(56%)男性,INSURE组有31例(62%)男性。LISA组婴儿的中位出生体重为1300克(四分位间距600),而INSURE组为1400克(四分位间距400)。LISA组和INSURE组的剖宫产率分别为52%(n = 26)和48%(n = 24)。LISA组38例患者(76%)和INSURE组30例患者(60%)接受了产前类固醇治疗。LISA组患者对机械通气的需求显著更少,p值<0.05{30%(n = 15)对60%(n = 30)}。LISA组和INSURE组机械通气的中位持续时间分别为40小时(四分位间距75)和71小时(四分位间距62)。同样,LISA组的中位FiO2降低值为30(四分位间距30),INSURE组为25(四分位间距10),p值<0.05。在死亡率、住院时间和并发症方面无显著差异。
LISA技术是一种安全、无创的肺表面活性物质给药方法,可降低机械通气率和持续时间。